UROMONITOR is transforming bladder cancer monitoring with a highly precise, non-invasive liquid biopsy approach.
Using a urine-based test, it detects highly sensitive and specific biomarkers associated with non-muscle-invasive bladder cancer (NMIBC), delivering accurate and reliable results. This offers an effective solution for recurrence detection in patients under routine surveillance.
With fast and dependable real-time PCR results, UROMONITOR serves as an alternative or complement to current standard-of-care (SOC) methods. In addition to significantly improving patients' quality of life by avoiding invasive procedures, it helps reduce the economic burden of NMIBC follow-up.
Our mission is to provide a simpler, more accessible solution that makes a meaningful impact for both patients and healthcare professionals, raising the standard of care in bladder cancer monitoring.
Company Details
- Employees
- 5
- Founded
- -
- Address
- Travessa Cruzes Do Monte, Maia,porto,portugal
- Industry
- Biotechnology
- Website
- uromonitor.com
- Keywords
- biomarker, non-muscle invasive bladder cancer, cancro bexiga, biomarcador, liquidbiopsy, NMIBC, Bladdercancer, Urinary test.
- HQ
- Maia, Porto
Uromonitor Questions
Uromonitor's website is uromonitor.com
Uromonitor's LinkedIn profile is https://pt.linkedin.com/company/uromonitor
Uromonitor has
5 employees.
View email and phone details for 5
employees at Uromonitor.
Uromonitor's industry is
Biotechnology
Uromonitor's top competitors are
Euromonitor International,
Clínica Dr. Passos Angelo,
Urología Bielsa&lorente,
Institute For Sexual Medicina, Andrology & Urology,
Share Path Strategies,
Eongenetics,
Comitas Consultancy,
Rainbow Colorful Talents,
Lista Candidata À Sporl-Ccp 2025-2028,
Laboratorio Pretoria S.r.l..
Uromonitor's categories are Biotechnology
Uromonitor's founding year is 2017
